Scotia Capital Inc. Pro Mis Neurosciences Inc. Call Options Transaction History
Scotia Capital Inc.
- $17.8 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PMN
# of Institutions
20Shares Held
10.1MCall Options Held
0Put Options Held
0-
Great Point Partners LLC Greenwich, CT2.79MShares$2.87 Million1.61% of portfolio
-
Armistice Capital, LLC New York, NY2.67MShares$2.75 Million0.06% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.93MShares$1.99 Million0.44% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY1.59MShares$1.64 Million1.41% of portfolio
-
Altium Capital Management LP New York, NY581KShares$598,8360.26% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...